中文名 | 7-溴-4-甲氧基-5-[(苯基甲氧基)甲基]-5H-吡咯并[3,2-d]嘧啶 |
---|---|
英文名 | 5-[(Benzyloxy)methyl]-7-bromo-4-methoxy-5H-pyrrolo[3,2-d]pyrimidi ne |
中文别名 | 7-N-苄氧基甲基-9-溴-9-去氮-6-O-甲基次黄嘌呤 |
英文别名 |
2,4-Diamino-6-methoxymethylpteridine
6-methoxymethyl-pteridine-2,4-diamine 5-[(Benzyloxy)methyl]-7-bromo-4-methoxy-5H-pyrrolo[3,2-d]pyrimidine 2,4-Diamino-6-methoxymethylpteridin 5H-Pyrrolo[3,2-d]pyrimidine, 7-bromo-4-methoxy-5-[(phenylmethoxy)methyl]- 7-N-benzyloxymethyl-9-bromo-9-deaza-6-O-methylhypoxanthine |
密度 | 1.5±0.1 g/cm3 |
---|---|
沸点 | 476.6±45.0 °C at 760 mmHg |
分子式 | C15H14BrN3O2 |
分子量 | 348.195 |
闪点 | 242.1±28.7 °C |
精确质量 | 347.026947 |
PSA | 49.17000 |
LogP | 3.63 |
蒸汽压 | 0.0±1.1 mmHg at 25°C |
折射率 | 1.641 |
储存条件 | 室温 |
~76% 299916-62-4 |
文献:BIOCRYST PHARMACEUTICALS, INC.; BABU, Yarlagadda, S.; KOTIAN, Pravin, L.; BANTIA, Shanta; WU, Minwan; KUMAR, V., Satish Patent: WO2014/78778 A2, 2014 ; Location in patent: Page/Page column 106-107 ; |
~% 299916-62-4 |
文献:BIOCRYST PHARMACEUTICALS, INC.; BABU, Yarlagadda, S.; KOTIAN, Pravin, L.; BANTIA, Shanta; WU, Minwan; KUMAR, V., Satish Patent: WO2014/78778 A2, 2014 ; |
~% 299916-62-4 |
文献:BIOCRYST PHARMACEUTICALS, INC.; BABU, Yarlagadda, S.; KOTIAN, Pravin, L.; BANTIA, Shanta; WU, Minwan; KUMAR, V., Satish Patent: WO2014/78778 A2, 2014 ; |
~% 299916-62-4 |
文献:BIOCRYST PHARMACEUTICALS, INC.; BABU, Yarlagadda, S.; KOTIAN, Pravin, L.; BANTIA, Shanta; WU, Minwan; KUMAR, V., Satish Patent: WO2014/78778 A2, 2014 ; |
~% 299916-62-4 |
文献:BIOCRYST PHARMACEUTICALS, INC.; BABU, Yarlagadda, S.; KOTIAN, Pravin, L.; BANTIA, Shanta; WU, Minwan; KUMAR, V., Satish Patent: WO2014/78778 A2, 2014 ; |
上游产品 5 | |
---|---|
下游产品 0 |